Around two thirds, or 65 per cent, of investors believe the fallout from Covid-19 will be worse in 2021 than it has been this year, according to a recent study by HYCM.
Covid-19 has stalled the emergence of new credit fund investment strategies and has pushed managers to focus on their existing credit platform products, according to a new report from global law firm Ropes & Gray.
Mountside Ventures and ALLOCATE, today released their inaugural annual report entitled, "Capital Behind Venture 2020." The report provides insights on Venture Capital (VC) firms looking to raise funds from Limited Partners (LPs) such as pension funds, university endowments, government agencies, fund-of-funds, and high net worth (HNW) individuals or family offices who actively invest in Europe's growing VC ecosystem.
Despite extreme levels of market volatility, increased trading volumes and disruptions to society due to Covid-19, alternative fund managers have persevered, and even exceeded, performance expectations from investors.
On Monday, BioNTech and Pfizer announced that their Covid-19 vaccine-in-the-making showed a 90 per cent efficiency rate in a late stage clinical trial, which sent share prices soaring around the world on the back of the scientific breakthrough.
Global investment firm KKR continues to see the Philippines as an attractive market amid the global pandemic, citing the fundamental strength of the country’s economy as well as its young and dynamic population.
Sidetrade, an Artificial Intelligence platform dedicated to accelerating company revenue and cashflow, has partnered with Hyman Capital to help the firm's clients and private equity contacts to adjust quickly to the Covid-19 pandemic in terms of cashflow generation.
A new report released by BGF and academic Sir Anthony Seldon is calling for urgent action to recapitalise 21,000 businesses – the UK’s growth economy companies.
A surge in deal activity over the next few months is being predicted by private equity house WestBridge, as business owners seek to realise and de-risk their assets ahead of widely anticipated changes to the Capital Gains Tax (CGT) regime in the next budget.
By Kieran Fox, Irish Funds – We are all well aware of the human and public health cost which Covid-19 has had since March of this year when its impact reverberated around the globe. Although general consensus is that we still have some way to go until there is a vaccine or other resolution to the pandemic, central banks and regulators are now beginning to look into the effect the crisis had on capital markets during the early days of its impact and seeking to learn lessons from this.